DeSci

$BIO
🚀 Bio Protocol (BIO): A Rising Star with High Potential! 🌟
As of January 3, 2025, Bio Protocol (BIO) is trading at approximately $0.8145, reflecting a 5.69% decrease over the past 24 hours.
Here's why BIO continues to be a standout in the decentralized science (DeSci) space:
1. Innovation at Its Core: Bio Protocol leverages blockchain technology to revolutionize biotech research, fostering transparency and community-driven innovation.
2. Strong Market Performance: Despite recent fluctuations, BIO has demonstrated significant growth, with a market capitalization of approximately $956 million and a circulating supply of 1.61 billion tokens.
3. Expanding Ecosystem: With plans to launch on Solana and other blockchain ecosystems in 2025, Bio Protocol aims to broaden its suite of BioDAOs and liquidity pools, including initiatives like Long COVID Labs and Curetopia.
4. Major Exchange Listings: Bio Protocol's listing on major exchanges like Binance has increased its accessibility and liquidity, attracting a broader investor base.
This is a project to watch and a token to consider for all crypto enthusiasts interested in the DeSci movement. Don't miss out on its high potential!
What are your thoughts on Bio Protocol's growth? Let me know in the comments! 💬
#BIOProtocol #DeSci #CryptoInvesting l#BlockchainTechnology #BIOOnBinance

Binance 63rd phase #Launchpool‬⁩ is ongoing, staking $BNB or FDUSD can earn BIO for free.
Bio Protocol (BIO) is a management and liquidity protocol for decentralized science (DeSci).
Based on staking returns, for the same staking amount, the returns from the FDUSD pool are higher than those from the BNB pool, as the BNB pool has more participants and total amount, resulting in relatively lower mining returns.
Currently, the pre-market trading price of BIO is $0.96, with high enthusiasm, and it may maintain this for a while after going online.
Bio Protocol mining returns

What is DeSci?
DeSci is decentralized science, a movement aimed at building public infrastructure for scientific research using Web3 technology.

The world of biotechnology is on the cusp of a major transformation, thanks to the BIO Protocol, a groundbreaking decentralized science (DeSci) initiative. With the mission to accelerate the development of biotech innovations through decentralized funding, ownership, and liquidity, BIO is not just a protocol—it's a movement to reshape how biotech research and advancements are funded, developed, and shared.
What is BIO Protocol?
BIO Protocol is a decentralized curation and liquidity protocol that empowers global communities of patients, scientists, and biotech professionals to collectively fund, develop, and own tokenized biotech projects and intellectual property (IP). By combining the power of decentralized finance (DeFi) with the potential of biotechnology, BIO is creating an onchain scientific economy that fosters innovation, collaboration, and financial sustainability.
The BIO Team and Its Legacy
The team behind BIO comes with a wealth of experience in the decentralized science and biotechnology space. They previously co-founded Molecule, a platform for tokenized biomedicine, and VitaDAO, a decentralized longevity science community. BIO Protocol builds on these achievements, pushing the boundaries of decentralized funding, incentives, and liquidity for biotech research and IP.
Features of BIO Protocol
BIO Token: The native governance token of the BIO protocol that grants access to scientific communities and the DeSci economy. For crypto enthusiasts, BIO acts as a bridge between bioconomy and the DeFi world, offering a launchpad for biotech innovations.BIO Incubator & BioDAO Bible: For scientists and biotech professionals, BIO offers a platform to launch, incubate, and manage biotech projects. These tools provide guidance on structuring bioDAOs (decentralized autonomous organizations) and offer funding and liquidity support.
How BIO Protocol Works
The BIO Protocol creates a financial layer that accelerates the development of biotech innovations through decentralized communities known as bioDAOs. These bioDAOs are essentially community-driven networks that pool resources such as capital, data, and labor to fund scientific research and development. By tokenizing IP, bioDAOs enable shared ownership of intellectual property, significantly reducing the cost of innovation.
Core Operations:
Curation:
BIO token holders use vBIO (locked BIO) to stake and vote on bioDAO applicants. Successful DAOs are granted ecosystem access, unlocking benefits for stakers.
Funding:
Accepted bioDAOs offer early-stage funding opportunities to vBIO stakers, leveling the playing field with institutional investors.
Liquidity:
BIO manages liquidity to ensure bioDAOs can focus on scientific progress without worrying about financial challenges.
Bio/acc Rewards:
The protocol rewards participants with BIO tokens for reaching significant milestones, such as successful clinical trials or the generation of valuable IP.
Meta-Governance:
BIO token holders have governance rights across bioDAOs, allowing them to influence decisions on funding, token issuance, and other critical aspects of the ecosystem.
Value Accrual and Use Cases
The BIO ecosystem creates multiple value channels, including:
Token Allocations: Grants to bioDAOs in exchange for token allocations, enabling the ecosystem to grow and diversify.Protocol-Owned Liquidity: BIO’s treasury grows through liquidity pools, creating a sustainable financial model.
BIO Token Use Cases:
Curating and governing bioDAOs.Gaining early access to token sales and IP assets.Receiving discounts on health products and services.Participating in governance across the ecosystem.
BioDAOs: A New Era of Biotech Innovation
BIO Protocol empowers the creation of bioDAOs, decentralized communities that drive scientific and medical R&D. By pooling resources like capital, data, and expert labor, bioDAOs help fund projects more efficiently, enabling the development of IP through shared ownership models.
Advantages of BioDAOs:
Capital Efficiency: Shared resources lower R&D costs and ensure more projects are funded.Flexible Work Models: Attract part-time expert contributions, reducing the reliance on full-time researchers.Open Access: Democratizes funding and decision-making, allowing everyone to have a voice in scientific progress.Shared IP Ownership: Incentivizes participation by offering shared ownership of valuable intellectual property.Diversified Portfolios: Reduces risk by funding multiple projects simultaneously.
Success Stories of BioDAOs
The BIO protocol has already seen significant success through various bioDAOs, each focusing on specific scientific fields. Here are a few noteworthy examples:
VitaDAO: Raised over $5M for longevity science, backed by Pfizer.HairDAO: Owns the patent for Follicool, a hair loss treatment.CerebrumDAO: Raised $1.5M to address brain health issues.ValleyDAO: Over $2M raised for synthetic biology research.AthenaDAO: Raised $500K for women’s health R&D.CryoDAO: Raised $3M for cryogenics research.PsyDAO: Focuses on psychedelic medicines for mental health.
BIO Cohort 2: Accelerating Specific Medical Frontiers
BIO’s second cohort is already pushing boundaries in specialized fields:
Long COVID Labs: Dedicated to finding cures for Long COVID.Quantum Biology DAO: Advancing quantum microscopes for bio research.Curetopia: Tackling rare diseases by leveraging patient communities.
BIO Protocol's Launchpad and Governance
BIO Protocol’s Launchpad provides a space for community-driven curation and funding of bioDAOs. The process follows three distinct phases:
Curation: BIO token holders pledge tokens to signal support for specific projects.Acceleration: BioDAOs raise funds and advance if the market supports them.Separation: Graduates to the Automated Market Maker (AMM) with liquidity pools backing its market presence.
BIO Token Genesis Auction
The BIO Genesis Auction is the token generation event (TGE) that serves as the first opportunity for participants to acquire BIO tokens. The auction occurs in two rounds, where participants swap DeSci tokens or ETH for BIO, with a focus on raising assets for liquidity and governance.
Auction 2 Summary: Targets a fully diluted valuation (FDV) of up to $100M, with 664 million BIO tokens (20% of the initial supply) distributed during both rounds. Participants claim 50% of their BIO tokens immediately and the remaining 50% as vBIO, which vests over a year.
BIO's Community Airdrop
BIO’s airdrop allocates 3% of the total BIO supply to over 8,500 qualified addresses. Users can claim vBIO, which can later be converted into BIO once approved by governance. The airdrop is a way to incentivize community participation and drive engagement within the BIO ecosystem.
Future of BIO Protocol
BIO Protocol is more than just a tool for biotech funding—it’s a platform for a new way of thinking about how science is funded, developed, and shared. By embracing decentralized finance, the BIO community is rewriting the future of biotech, creating a more inclusive, transparent, and efficient ecosystem for everyone involved, from scientists to patients and crypto enthusiasts alike.

#BIO #BIOProtocol #DeSciRising #DeSci #DeSci热度上涨

🚨 BIO Protocol ($BIO) Now Trading on Binance! 🚨

🌟 Current Price: $0.952
📊 24H Trading Volume: $867,623
💎 Market Cap: $1.20 Billion

🔑 What You Need to Know:
• Already Listed Elsewhere: Before Binance, $BIO was trading on smaller, less trusted exchanges, where early trading activity pushed the price up significantly.

• High Volatility & Risks: Early momentum may already be priced in, and risks of a correction are high as Binance introduces more liquidity.
• Strong Fundamentals: BIO revolutionizes biotech funding with tokenized IP, but market adoption and execution risks remain.

💡 Trading Tips:$ETH
• Avoid Overpaying: The price has already surged. Use limit orders to get a fair entry point (e.g., $0.90–$0.95).
• Short-Term Volatility: Watch for corrections before committing to long-term positions.
📈 Start trading $BIO now on Binance Spot, but remember to trade cautiously!

#BIO #CryptoTrading #DeSci #BIOOnBinance #TradeSmart

$BIO

Protocol has sparked significant interest in the crypto world, especially following its launch on Binance. Despite its extreme price fluctuations—rising as much as 2400% before seeing a major dip—BIO Protocol's long-term potential lies beyond these market dynamics. While its volatility might raise concerns among investors, it's crucial to recognize the substantial partnerships and backing that support the project, positioning it as an innovative force in biotech funding.
Key Backers and Collaborations
BIO Protocol’s credibility comes from its collaborations with leading academic institutions and industry giants. Notably, Newcastle University and Imperial College London are among the key educational partners. Additionally, the University of Copenhagen and its ties to VitaDAO—a core project within the BIO ecosystem—are crucial to its scientific foundation. On the corporate side, Pfizer Ventures has notably backed VitaDAO in a substantial funding round, signaling significant institutional interest. Other prominent figures, like Balaji Srinivasan, former CTO of Coinbase, and Juan Benet, the founder of Filecoin, have lent their support, further validating the project’s credibility.
Disrupting the Traditional Biotech Model
At the heart of BIO Protocol is its mission to revolutionize the way biotech research is funded and managed. The platform uses blockchain to create transparency and democratize the process, allowing scientists, investors, and patients to directly participate in funding biotech innovations. This approach challenges the traditional venture capital model and aims to streamline the development of underfunded areas of research, such as longevity and rare diseases. Through its BIO Launchpad and BioDAO Incubator, BIO Protocol is setting up an ecosystem to foster decentralized biotech projects, providing a new avenue for growth and innovation in this crucial sector.
Overcoming Challenges and Building Trust
While the BIO Protocol project has garnered significant institutional backing, it faces challenges that are common with emerging technologies, particularly in the intersection of biotech and blockchain. The volatility of the market, particularly in the crypto space, has led to skepticism, particularly following its dramatic price swings. However, this market fluctuation should be understood as part of the speculative nature of crypto rather than a reflection of the project’s inherent value. BIO Protocol’s real challenge lies in educating the broader market about decentralized science (DeSci) and overcoming regulatory hurdles as it aims to disrupt the biotech sector.
Final Thoughts
BIO Protocol represents an ambitious vision to reshape biotech funding through decentralization. While the price volatility may have cooled some investor enthusiasm, the partnerships and backing from reputable institutions signal a promising future. As the project matures and educates the market on the potential of blockchain-powered biotech solutions, it could significantly alter the landscape of scientific research funding. Those looking at BIO Protocol should be mindful of the risks but also remain aware of its potential to revolutionize the biotech industry in the long run.
#BIOProtocol #DeSci #BlockchainInnovation #BiotechRevolution

$BIO

The evolution and understanding of DeSci.
In the field of knowledge exploration and sharing, there have long been a series of pain points, particularly regarding the lagging infrastructure for the maintenance, access, ownership, and revenue distribution of IP related to research or knowledge. These issues are especially prominent in academia. Balancing security, transparency, reward mechanisms, and accessibility in the complex field of knowledge sharing and discovery has always been a persistent challenge. Traditional models typically rely on centralized verification systems, which limit inclusivity and widespread participation, while existing systems may fail to adequately reward or recognize knowledge contributions, thereby impacting the development of a comprehensive and collective knowledge base.